Alnylam Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 5.48, this is below the company average, and notable indication of worsening business environment. Average collection period, for Alnylam Pharmaceuticals Inc 's accounts receivable remained unchanged at 67 days, in the Sep 30 2026 quarter.

If we take a look into Healthcare sector 348 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 1041 to 2532.

What is Receivable Turnover Ratio?
What is Alnylam Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ALNY Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	12.45 %	60.95 %	111.46 %	91.85 %	172.65 %
Y / Y Revenue Change	16.74 %	66.86 %	96.43 %	84.95 %	149.35 %
Receivable Turnover Ratio (TTM)	5.48	5.43	5.37	5.45	5.45
ALNY's Total Ranking	# 2532	# 1041	# 589	# 1391	#
Accounts Receivable average collection period days	67	67	68	67	67
Seq. Receivable Change	18.86 %	3.26 %	13.68 %	-19.4 %	70.12 %
Seq. Revenue Change	12.95 %	10.6 %	6.39 %	-12.17 %	61.44 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 103
Healthcare Sector	# 349
Overall Market	# 2532

Receivable Turnover Ratio Statistics
High	Average	Low
103.56	13.27	3.23
(Sep 30 2013)		(Mar 31 2018)

ALNY Company Profile • Back to ALNY Efficiency Comparisons • Compare ALNY Receivables Turnover Ratio to its Competitors

Financial Statements
Alnylam Pharmaceuticals Inc 's Accounts Receivable	$ 1,085 Millions	Visit ALNY's Balance sheet
Alnylam Pharmaceuticals Inc 's Sales TTM	$ 5,013 Millions	Visit ALNY's Income Statement
Sources of ALNY's Revenues		Visit ALNY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ALNY's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ALNY's Growth Rates	ALNY's Roa	ALNY's Inventory Turnover Ratio	ALNY's Dividend Comparisons
ALNY's Profitability Ratios	ALNY's Roi	ALNY's Asset Turnover Ratio	ALNY's Dividend Growth
ALNY's Valuation Ratios	ALNY's Roe	ALNY's Financial Strength Ratios	ALNY's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Chemed Corporation	12.65	$ 2,661.041 Millions	$ 210.387 Millions
Caredx Inc	11.75	$ 497.396 Millions	$ 42.330 Millions
Teladoc Health Inc	11.50	$ 2,468.143 Millions	$ 214.604 Millions
Iqvia Holdings Inc	10.43	$ 17,311.000 Millions	$ 1,659.500 Millions
Bausch Health Companies Inc	9.15	$ 11,113.000 Millions	$ 1,215.000 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Pediatrix Medical Group Inc	8.57	$ 1,959.124 Millions	$ 228.471 Millions
Tenet Healthcare Corp	8.54	$ 22,154.000 Millions	$ 2,593.250 Millions
Penumbra Inc	8.22	$ 1,560.334 Millions	$ 189.735 Millions
Alphatec Holdings Inc	7.91	$ 839.652 Millions	$ 106.153 Millions
Exelixis Inc	7.89	$ 2,496.861 Millions	$ 316.636 Millions
Merit Medical Systems Inc	7.53	$ 1,612.236 Millions	$ 214.065 Millions
Insmed Inc	7.45	$ 1,479.040 Millions	$ 198.502 Millions
Novocure Limited	7.44	$ 725.388 Millions	$ 97.525 Millions
Intuitive Surgical Inc	7.44	$ 12,115.600 Millions	$ 1,629.350 Millions
Quest Diagnostics Inc	7.43	$ 11,841.000 Millions	$ 1,593.250 Millions
Beta Bionics Inc	7.15	$ 127.899 Millions	$ 17.897 Millions
Angiodynamics Inc	7.13	$ 323.784 Millions	$ 45.418 Millions
Hca Healthcare Inc	6.85	$ 78,701.000 Millions	$ 11,495.250 Millions
Medpace Holdings Inc	6.73	$ 2,838.385 Millions	$ 421.525 Millions
Carlisle Companies Incorporated	6.67	$ 5,213.500 Millions	$ 781.625 Millions
3m Company	6.59	$ 25,247.000 Millions	$ 3,832.500 Millions
Baxter International Inc	6.55	$ 11,784.000 Millions	$ 1,799.500 Millions
Healthcare Services Group Inc	6.36	$ 1,879.860 Millions	$ 295.784 Millions
Integra Lifesciences Holdings Corp	6.26	$ 1,656.786 Millions	$ 264.861 Millions
Neogen Corporation	6.17	$ 884.120 Millions	$ 143.371 Millions
Mimedx Group Inc	6.06	$ 303.363 Millions	$ 50.077 Millions
Avantor Inc	5.98	$ 6,635.600 Millions	$ 1,110.300 Millions
Conmed Corporation	5.76	$ 1,369.288 Millions	$ 237.544 Millions

Date modified: 2026-10-30T17:00:10+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.